로딩 중…
지수 로딩 중…
Oruka Therapeutics, Inc.
ORKA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$72.33+2.05%
2026-06-18
Price Chart
Oruka Therapeutics, Inc.+503.76%
Financials
No data
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $4.36B |
| Revenue | $0.00 |
| Net Income | $-116M |
| Total Assets | $504M |
| Net Assets | $487M |
| Value | |
| P/B | 8.96x |
| FCF Yield | -2.09% |
| Profitability | |
| ROE | -23.89% |
| ROA | -23.04% |
| Financial Health | |
| Debt Ratio | 3.65% |
| Total Debt | $2M |
| FCF | $-91M |
| Cash | $50M |
| Current Ratio | 23.76x |
| Performance | |
| 1Y Return | 503.76% |
| 1M Return | 25.79% |
| From 52W High | -20.52% |
| 1Y MDD | -27.99% |
| Trading | |
| Volume | 2,303,817 shares |
| Trading Value | $167M |
| Per Share | |
| EPS | $-1.94 |
| BPS | $8.67 |